A Randomised, Placebo-controlled, Double-blind, Dose Escalation Study in Healthy Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of Rectal Suppositories Containing Between 5 and 15 mg NRL001 or Matching Placebo for Two Different Sized Suppositories (1 g and 2 g).
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Methoxamine (Primary)
- Indications Faecal incontinence
- Focus Pharmacokinetics
- Sponsors Norgine
- 21 May 2014 New trial record